These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8429648)

  • 1. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
    Cmolik BL; Spero JA; Magovern GJ; Clark RE
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):222-7; discussion 227-8. PubMed ID: 8429648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases.
    Poynton AR; Nelson MC; McCance SE; Levine RL; O'Leary PF
    Spine (Phila Pa 1976); 2003 Jun; 28(12):E221-3. PubMed ID: 12811284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases.
    Spero JA
    J Neurosurg; 1993 May; 78(5):817-20. PubMed ID: 8468613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated coagulopathy: a case report.
    Naoum JJ
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
    Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
    J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.
    Adams JD; Jones S; Brost BC
    J Reprod Med; 2001 Oct; 46(10):909-12. PubMed ID: 11725736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency.
    Lim S; Zuha R; Burt T; Chacko J; Scott R; Mainwaring CJ
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):667-71. PubMed ID: 17102654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
    Savage WJ; Kickler TS; Takemoto CM
    Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired factor V deficiency associated with exposure to bovine thrombin in a burn patient.
    Foster KN; Kim H; Potter K; Matthews MR; Pressman M; Caruso DM
    J Burn Care Res; 2010; 31(2):353-60. PubMed ID: 20182366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
    Madura JA; Rookstool M; Wease G
    Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin.
    Crow SS; Sullivan VV; Aysola AE; Key NS; Harker-Murray P; Foker JE; Steiner ME
    Ann Thorac Surg; 2007 Apr; 83(4):1547-9. PubMed ID: 17383385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
    de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
    Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.
    Bomgaars L; Carberry K; Fraser C; West A; Teruya J
    Congenit Heart Dis; 2010; 5(3):303-8. PubMed ID: 20576051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
    Tarantino MD; Ross MP; Daniels TM; Nichols WL
    J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer.
    Caers J; Reekmans A; Jochmans K; Naegels S; Mana F; Urbain D; Reynaert H
    Endoscopy; 2003 Jun; 35(6):542-4. PubMed ID: 12783357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoprecipitate-topical thrombin glue. Initial experience in patients undergoing cardiac operations.
    Lupinetti FM; Stoney WS; Alford WC; Burrus GR; Glassford DM; Petracek MR; Thomas CS
    J Thorac Cardiovasc Surg; 1985 Oct; 90(4):502-5. PubMed ID: 3930885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.